Cancer News and Research

Latest Cancer News and Research

UAB researchers and information technology specialists win the caBIG- 2009 Deployment Award

A team of researchers and information technology specialists at the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center has won the caBIG- 2009 Deployment Award from the National Cancer Institute (NCI).

24 Aug 2009

Health care profiles: Kennedy, Daschle and Kratovil

News reports this weekend explored some prominent personalities in health reform, as well as a new one. Sen. Edward Kennedy, D-Mass., continues to battle brain cancer at home, but his illness has taken on symbolic proportions in the debate.

24 Aug 2009

Rhode Island Hospital to identify a model for integrating screening and brief interventions for alcohol misuse

There are an estimated 7.6 million alcohol-related emergency department (ED) visits each year in the country. A first step in identifying an alcohol problem is screening all ED patients utilizing two well-researched screening tests.

24 Aug 2009

Orphan drug status granted to BioCancell's BC-819 drug

Tikcro Technologies today announced that the United States (“US”) Department of Health and Human Services ("HHS") has granted orphan drug status to BioCancell's BC-819 drug, currently in Phase I/IIa clinical trials, for its use in treating ovarian cancer.

24 Aug 2009

Santaris Pharma to discover and develop new RNA-based medicines for treating rare genetic disorders

Santaris Pharma A/S, a privately-held biopharmaceutical company focused on developing RNA-based drugs targeted to disease-related mRNAs and microRNAs, today announced a multi-year worldwide strategic alliance with Shire plc to discover and develop new RNA-based medicines to treat rare genetic disorders.

24 Aug 2009

Aflac releases eighth new television commercial of 2009

Aflac today unveiled its eighth new television commercial of 2009, titled "Soccer." This commercial showcases the Aflac Duck as the web-footed star of the team, who helps provide a solid defense against unexpected medical bills. "Soccer" will debut on August 24, running nationally on CBS, ABC, FOX, NBC, CNN, CNBC, Discover Channel, USA, Headline News and the History Channel.

24 Aug 2009

Capital Earnings & Research to launch prostate cancer awareness campaign

What did all the following businessmen have in common?

24 Aug 2009

ARIAD's petition for rehearing the Lilly NF-Kb patent lawsuit is granted by the Federal Circuit

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) and its co-plaintiffs today announced that the U.S. Court of Appeals for the Federal Circuit (the “Federal Circuit”) has granted their petition for rehearing en banc and has vacated its April 2009 decision in the appeal that Eli Lilly and Co. filed in 2008. All twelve judges of the Federal Circuit will now rehear and reassess the merits of Lilly’s appeal.

24 Aug 2009

Simcere to collaborate with Sun Yat-Sen University Cancer Center to research and develop anti-cancer drugs

Located in Guangzhou, Sun Yat-Sen University Cancer Center is one of China's renowned cancer research institutions, prominent in pre-clinical and clinical oncology research. The Sun Yat-Sen University Cancer Center was established to research anti-cancer treatments with a specific focus on developing major innovative drugs.

24 Aug 2009

Study reveals that treating Alzheimer's disease with DHA and EPA slows down its progression

Scientists have identified the inflammatory process as the common soil in a diverse range of chronic degenerative diseases. The news, recently reported in the LA Times article, discusses how foods like cherries may help rheumatoid arthritis or avoidance of gluten may fight off psoriasis.

24 Aug 2009

UCLA's Laboratory of Neuro Imaging awarded $1.9 million NIH ARRA grant

UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.

24 Aug 2009

Two key circuits for controlling the cell's ability identified by UCSF researchers

UCSF researchers have identified the two key circuits that control a cell's ability to adapt to changes in its environment, a finding that could have applications ranging from diabetes and autoimmune research to targeted drug development for complex diseases.

24 Aug 2009

Primary cilia can suppress or promote skin cancer

Tiny, solitary spikes that stick out of nearly every cell in the body play a central role in a type of skin cancer, new research has found. The discovery in mice shows that the microscopic structures known as primary cilia can either suppress or promote this skin cancer, depending on the mutation triggering the disease.

24 Aug 2009

Research reveals that diarrheal bacteria can cause colon cancers

Johns Hopkins scientists say they have figured out how bacteria that cause diarrhea may also be the culprit in some colon cancers. The investigators say that strains of the common Bacteroides fragilis (ETBF) dupe immune system cells into permitting runaway colon tissue inflammation, a precursor for malignant growth.

24 Aug 2009

New technique may help clinicians in diagnosing pleural effusion

A new technique may help clinicians hone in on a diagnosis in patients presenting with a pleural effusion of unknown cause.

24 Aug 2009

DS Waters of America forges alliance with breast cancer advocacy group

DS Waters of America, Inc., a leader in the home and office bottled water, filtration and office coffee delivery service today announced it has entered a three-year alliance with Susan G. Komen for the Cure(R), the world's largest breast cancer advocacy group.

24 Aug 2009

Tiny filaments extending from cells may play a role in common malignant brain tumors

UCSF scientists have discovered that a tiny filament extending from cells, until recently regarded as a remnant of evolution, may play a role in the most common malignant brain tumor in children.

24 Aug 2009

Cell Therapeutics' NDA for Pixantrone accepted by the FDA

Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has accepted and has filed for review the Company's New Drug Application (NDA) for pixantrone as treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL). A Prescription Drug User Fee Act (PDUFA) date will be established by the FDA regarding the review of the pixantrone NDA by September 4th 2009.

24 Aug 2009

Recently diagnosed young adults with blood-related cancers have better long-term survival rates

A new analysis has found that adolescents and young adults who were recently diagnosed with blood-related cancers have better long-term survival rates than those who were diagnosed in the 1980s. Published in the November 1, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that significant advances have been made in the treatment of 15 to 24 year-olds with leukemias and lymphomas; however, survival rates in this age group are still lower than those seen in younger children.

24 Aug 2009

High serum insulin levels linked with increased risk of prostate cancer

Demetrius Albanes, M.D., of the Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics at the National Cancer Institute in Bethesda, Md., and colleagues investigated the relationship of the level of serum insulin and glucose, as well as surrogate indices of insulin resistance, to the development of prostate cancer.

24 Aug 2009

Cancer News and Research

Latest Cancer News and Research

UAB researchers and information technology specialists win the caBIG- 2009 Deployment Award

Health care profiles: Kennedy, Daschle and Kratovil

Rhode Island Hospital to identify a model for integrating screening and brief interventions for alcohol misuse

Orphan drug status granted to BioCancell's BC-819 drug

Santaris Pharma to discover and develop new RNA-based medicines for treating rare genetic disorders

Aflac releases eighth new television commercial of 2009

Capital Earnings & Research to launch prostate cancer awareness campaign

ARIAD's petition for rehearing the Lilly NF-Kb patent lawsuit is granted by the Federal Circuit

Simcere to collaborate with Sun Yat-Sen University Cancer Center to research and develop anti-cancer drugs

Study reveals that treating Alzheimer's disease with DHA and EPA slows down its progression

UCLA's Laboratory of Neuro Imaging awarded $1.9 million NIH ARRA grant

Two key circuits for controlling the cell's ability identified by UCSF researchers

Primary cilia can suppress or promote skin cancer

Research reveals that diarrheal bacteria can cause colon cancers

New technique may help clinicians in diagnosing pleural effusion

DS Waters of America forges alliance with breast cancer advocacy group

Tiny filaments extending from cells may play a role in common malignant brain tumors

Cell Therapeutics' NDA for Pixantrone accepted by the FDA

Recently diagnosed young adults with blood-related cancers have better long-term survival rates

High serum insulin levels linked with increased risk of prostate cancer

Understanding the DNA Damage Response in Innate Immunity eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in